Relationship between cannabis and psychosis: Reasons for use and associated clinical variables

Psychiatry Research

Volumn 229, Issue 1-2, 2015, Pages 70-74

  Mané, Anna ^a,b   Fernández Expósito, Miguel ^c   Bergé, Daniel ^a,b   Gómez Pérez, Laura ^a   Sabaté, Agnés ^a   Toll, Alba ^a   Diaz, Laura ^a   Diez Aja, Cristobal ^a   Perez, Victor ^a,b  

^a HOSPITAL DEL MAR   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Cannabis; First episode; Reasons for use; Schizophrenia; Self medication

Indexed keywords

ADULT; ARTICLE; CANNABIS ADDICTION; CANNABIS USE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; ONSET AGE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; QUESTIONNAIRE; SELF MEDICATION; SEX DIFFERENCE; SYMPTOMATOLOGY; ADOLESCENT; AGE; CROSS-SECTIONAL STUDY; HALLUCINATIONS; MARIJUANA ABUSE; PROSPECTIVE STUDY; PSYCHOLOGY; PSYCHOTIC DISORDERS; RISK FACTOR; SCHIZOPHRENIA; YOUNG ADULT;

CANNABIS;

ADOLESCENT; ADULT; AGE FACTORS; CANNABIS; CROSS-SECTIONAL STUDIES; FEMALE; HALLUCINATIONS; HUMANS; MALE; MARIJUANA ABUSE; PROSPECTIVE STUDIES; PSYCHOPATHOLOGY; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF MEDICATION; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84939468886     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.07.070     Document Type: Article

References (45)

1. Addington J., Duchak V. Reasons for substance use in schizophrenia. Acta Psychiatr. Scand. 1997, 96(5):329-333.
2. Amorim P., Lecrubier Y., Weiller E., Hergueta T., Sheehan D. DSM-IH-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI. Eur. Psychiatry 1998, 13(1):26-34.
3. Andreasson S., Allebeck P., Rydberg U. Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County. Acta Psychiatr. Scand. 1989, 79(5):505-510.
4. Archie S., Boydell K.M., Stasiulis E., Volpe T., Gladstone B.M. Reflections of young people who have had a first episode of psychosis: what attracted them to use alcohol and illicit drugs?. Early Interv. Psychiatry 2013, 7(2):193-199.
5. Barnes T.R., Mutsatsa S.H., Hutton S.B., Watt H.C., Joyce E.M. Comorbid substance use and age at onset of schizophrenia. Br. J. Psychiatry 2006, 188:237-242.
6. Barrowclough C., Emsley R., Eisner E., Beardmore R., Wykes T. Does change in cannabis use in established psychosis affect clinical outcome?. Schizophr. Bull. 2013, 39(2):339-348.
7. Beavan V., Read J. Hearing voices and listening to what they say: the importance of voice content in understanding and working with distressing voices. J. Nerv. Ment. Dis. 2010, 198(3):201-205.
8. Broussard B., Kelley M.E., Wan C.R., Cristofaro S.L., Crisafio A., Haggard P.J., Myers N.L., Reed T., Compton M.T. Demographic, socio-environmental, and substance-related predictors of duration of untreated psychosis (DUP). Schizophr. Res. 2013, 148(1-3):93-98.
9. Brune M., Schaub D. Mental state attribution in schizophrenia: what distinguishes patients with "poor" from patients with "fair" mentalising skills?. Eur. Psychiatry 2012, 27(5):358-364.
10. Burns J.K., Jhazbhay K., Emsley R. Cannabis use predicts shorter duration of untreated psychosis and lower levels of negative symptoms in first-episode psychosis: a South African study. Afr. J. Psychiatry 2010, 13(5):395-399.
11. Burns J.K. Cannabis use and duration of untreated psychosis: a systematic review and meta-analysis. Curr. Pharm. Des. 2012, 18(32):5093-5104.
12. Caballero A., Tseng K.Y. Association of cannabis use during adolescence, prefrontal CB1 receptor signaling, and schizophrenia. Front. Pharmacol. 2012, 3:101.
13. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., Taylor A., Arseneault L., Williams B., Braithwaite A., Poulton R., Craig I.W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol. Psychiatry 2005, 57(10):1117-1127.
14. Compton M.T., Kelley M.E., Ramsay C.E., Pringle M., Goulding S.M., Esterberg M.L., Stewart T., Walker E.F. Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients. Am. J. Psychiatry 2009, 166(11):1251-1257.
15. Di Forti M., Sallis H., Allegri F., Trotta A., Ferraro L., Stilo S.A., Marconi A., La Cascia C., Reis Marques T., Pariante C., Dazzan P., Mondelli V., Paparelli A., Kolliakou A., Prata D., Gaughran F., David A.S., Morgan C., Stahl D., Khondoker M., MacCabe J.H., Murray R.M. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr. Bull. 2014, 40(6):1509-1517.
16. Dickerson F.B. Women, aging, and schizophrenia. J. Women Aging 2007, 19(1-2):49-61.
17. Dixon L., Haas G., Weiden P.J., Sweeney J., Frances A.J. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am. J. Psychiatry 1991, 148(2):224-230.
18. Fowler I.L., Carr V.J., Carter N.T., Lewin T.J. Patterns of current and lifetime substance use in schizophrenia. Schizophr. Bull. 1998, 24(3):443-455.
19. Gerretsen P., Plitman E., Rajji T.K., Graff-Guerrero A. The effects of aging on insight into illness in schizophrenia: a review. Int. J. Geriatr. Psychiatry 2014, 29(11):1145-1161.
20. Gomez Perez L., Santacana A.M., Berge Baquero D., Perez-Sola V. Reasons and subjective effects of cannabis use among people with psychotic disorders: a systematic review. Actas Esp. Psiquiatr. 2014, 42(2):83-90.
21. Goswami S., Mattoo S.K., Basu D., Singh G. Substance-abusing schizophrenics: do they self-medicate?. Am. J. Addict. 2004, 13(2):139-150.
22. Grech A., Van Os J., Jones P.B., Lewis S.W., Murray R.M. Cannabis use and outcome of recent onset psychosis. Eur. Psychiatry 2005, 20(4):349-353.
23. Green B., Kavanagh D.J., Young R.M. Reasons for cannabis use in men with and without psychosis. Drug Alcohol Rev. 2004, 23(4):445-453.
24. Haberstick B.C., Young S.E., Zeiger J.S., Lessem J.M., Hewitt J.K., Hopfer C.J. Prevalence and correlates of alcohol and cannabis use disorders in the United States: results from the national longitudinal study of adolescent health. Drug Alcohol Depend. 2014, 136:158-161.
25. Kay S.R., Fiszbein A., Vital-Herne M., Fuentes L.S. The Positive and Negative Syndrome Scale-Spanish adaptation. J. Nerv. Ment. Dis. 1990, 178(8):510-517.
26. Khantzian E.J. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am. J. Psychiatry 1985, 142(11):1259-1264.
27. Khantzian E.J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv. Rev. Psychiatry 1997, 4(5):231-244.
28. Kolliakou A., Castle D., Sallis H., Joseph C., O'Connor J., Wiffen B., Gayer-Anderson C., McQueen G., Taylor H., Bonaccorso S., Gaughran F., Smith S., Greenwood K., Murray R.M., Di Forti M., Atakan Z., Ismail K. Reasons for cannabis use in first-episode psychosis: does strength of endorsement change over 12 months?. Eur. Psychiatry 2015, 30(1):152-159.
29. Koskinen J., Lohonen J., Koponen H., Isohanni M., Miettunen J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr. Bull. 2010, 36(6):1115-1130.
30. Large M., Sharma S., Compton M.T., Slade T., Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch. Gen. Psychiatry 2011, 68(6):555-561.
31. Lewis D.A., Lieberman J.A. Catching up on schizophrenia: natural history and neurobiology. Neuron 2000, 28(2):325-334.
32. Linszen D.H., Dingemans P.M., Lenior M.E. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch. Gen. Psychiatry 1994, 51(4):273-279.
33. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370(9584):319-328.
34. Myles N., Newall H., Nielssen O., Large M. The association between cannabis use and earlier age at onset of schizophrenia and other psychoses: meta-analysis of possible confounding factors. Curr. Pharm. Des. 2012, 18(32):5055-5069.
35. Rossler W., Riecher-Rossler A., Angst J., Murray R., Gamma A., Eich D., van Os J., Gross V.A. Psychotic experiences in the general population: a twenty-year prospective community study. Schizophr. Res. 2007, 92(1-3):1-14.
36. Saddichha S., Prakash R., Sinha B.N., Khess C.R. Perceived reasons for and consequences of substance abuse among patients with psychosis. Prim. Care Companion J. Clin. Psychiatry 2010, 12:5.
37. Schaub M., Fanghaenel K., Stohler R. Reasons for cannabis use: patients with schizophrenia versus matched healthy controls. Aust. N. Z. J. Psychiatry 2008, 42(12):1060-1065.
38. Schimmelmann B.G., Conus P., Cotton S., Kupferschmid S., McGorry P.D., Lambert M. Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis. Eur. Psychiatry 2012, 27(6):463-469.
39. Schneier F.R., Siris S.G. A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice. J. Nerv. Ment. Dis. 1987, 175(11):641-652.
40. Schofield D., Tennant C., Nash L., Degenhardt L., Cornish A., Hobbs C., Brennan G. Reasons for cannabis use in psychosis. Aust. N. Z. J. Psychiatry 2006, 40(6-7):570-574.
41. Semple D.M., McIntosh A.M., Lawrie S.M. Cannabis as a risk factor for psychosis: systematic review. J. Psychopharmacol. 2005, 19(2):187-194.
42. Spencer C., Castle D., Michie P.T. Motivations that maintain substance use among individuals with psychotic disorders. Schizophr. Bull. 2002, 28(2):233-247.
43. Stone J.M., Fisher H.L., Major B., Chisholm B., Woolley J., Lawrence J., Rahaman N., Joyce J., Hinton M., Johnson S., Young A.H. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation. Psychol. Med. 2014, 44(3):499-506.
44. van Dijk D., Koeter M.W., Hijman R., Kahn R.S., van den Brink W. Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study. Schizophr. Res. 2012, 137(1-3):50-57.
45. Warner R., Taylor D., Wright J., Sloat A., Springett G., Arnold S., Weinberg H. Substance use among the mentally ill: prevalence, reasons for use, and effects on illness. Am. J. Orthopsychiatry 1994, 64(1):30-39.